Our lawyers are reviewing potential lawsuits for people who developed Burkholderia cepacia (B. cepacia) infections after using antiseptic wipes, liquid stool softeners, barrier cream cloths or other products.
Free Confidential Lawsuit Evaluation: If you or a loved one developed a B. Cepacia infection, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
What is B. Cepacia?
Burkholderia cepacia is a type of antibiotic-resistant bacteria commonly found in the soil and water, according to the Centers for Disease Control and Prevention (CDC). While the bacteria typically poses little threat to healthy adults, it can cause severe infections in people with weakened immune systems or chronic lung diseases like cystic fibrosis. The mortality rate associated with B. Cepacia infection is roughly 42%, according to the CDC.
B. Cepacia Outbreaks
Outbreaks of B. cepacia infection have been linked to the following products:
- Antiseptic wipes – In August 2012, the Dukal Corporation announced a recall for selected lots of benzalkonium chloride swabs and antiseptic wipes over concerns about potential B. cepacia contamination.
- Baby wipes – Nutek Disposables, Inc. issued a nationwide recall in October 2014 for baby wipes manufactured under the brand names Cuties, Diapers.com, Femtex, Fred’s, Kidgets, Member’s Mark, Simply Right, Sunny Smiles, Tender Touch, and Well Beginnings, because some packages may contain B. cepacia.
- Comfort Shield Barrier Cream Cloth – Recalled for potential B. cepacia contamination in August 2016. Affected products include Comfort Shield Barrier Cream Cloths, Incontinence Clean-Up Cloths, M-care Meatal Cleansing Cloths for the Foley Catheterized Patient, Comfort Bath Cleansing Washcloths, and 2% Chlorhexidine Gluconate Cloths.
- Body Milk – 2008 study published in the Journal of Critical Care looked at 5 hospitalized patients who developed B. cepacia infections from unopened bottles of moisturizing body milk, “calling into question the use in critical care settings of cosmetic products that do not guarantee sterilization during the manufacturing process.”
- I.V. Flush Syringes – On October 5, 2016, Nurse Assist, Inc. recalled all unexpired lots of its I.V. flush syringes after reports of patients developing B. cepacia infections while receiving intravenous care using prepackaged saline flushes.
- Mouthwash – Study published in the International Journal of Infectious Diseases (IJID) in December 2014 found contaminated alcohol-free mouthwash to be the source of B. cepacia colonization and infection in ICU patients undergoing mechanical ventilation.
- Stool softener – In July 2016, the FDA and CDC announced they were investigating a multistate outbreak of B. cepacia linked to contaminated liquid docusate product that infected at least 60 people in 8 states.
Signs and symptoms of B. cepacia infection include:
- Shortness of breath
Since B. cepacia is often resistant to common antibiotics, the infection is difficult to treat once its reached the lungs. However, some species may be successfully treated with a combination of antibiotics. Basic infection prevention and control practices can significantly reduce the risk of contracting or spreading B. cepacia.
Do I Have a B. Cepacia Lawsuit?
The Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in B. Cepacia infection lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
Free Case Evaluation: Again, if you or a loved one was infected, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.